A corporate venture capital, or CVC, thesis connects an investment opportunity to an established company's capabilities, problems, and strategic choices. It becomes useful when it explains why owning a stake in a startup could create value beyond hiring a supplier. Access to technology, technical learning, and service priority can come from commercial contracts. None of these benefits alone demonstrates that an equity stake is attractively priced.
Explain why the corporation should become an investor
The thesis should distinguish strategic results for the sponsoring corporation from financial results for whoever bears the equity risk. Strategic benefits might include access to technology, faster implementation, or entry into a production chain. Financial outcomes depend on entry price, contractual rights, dilution, value creation, and an opportunity to realize proceeds. Savings within the sponsor's operations do not automatically become cash for the startup's shareholders.
A useful statement identifies the problem, target customers, the capability the sponsor lacks, and how the startup could capture value. For example, a thesis might support businesses that reduce industrial process failures through solutions that can be replicated across manufacturers. This is more selective than seeking any artificial intelligence business. It supports specific questions about data, integration, responsibility for errors, and independent customers' willingness to pay.
The document should also state what would invalidate the thesis. An apparent advantage may disappear if it requires exclusive access to data that cannot be shared. A business may struggle to scale if every installation becomes an entirely new development project. Recording rejection conditions helps prevent decision makers from reinterpreting every outcome as confirmation, and gives subsequent reviews a meaningful reference point.
Turn strategic intentions into verifiable boundaries
An actionable thesis sets boundaries for sourcing and selection: problem types, product maturity, intended customers, capital needs, technical dependencies, and development horizon. Artificial precision is unnecessary, but the team must distinguish portfolio constraints from working hypotheses. A very broad maturity range, for example, may conceal incompatible support needs. Financing early research and supporting an established product's expansion require different resources and oversight.
Selection criteria should separate essential requirements from negotiable preferences. Demonstrating legitimate rights to core intellectual property may be necessary to proceed. Previous industry experience among founders might be desirable but offset by technical expertise and access to specialists. Mixing these categories allows commercial enthusiasm to override risks that should stop the review, while producing inconsistent treatment of otherwise comparable opportunities.
Each boundary needs an economic or operational rationale. Requiring a testable product makes sense when the sponsor can fund a short pilot but cannot support prolonged research. Rejecting broad exclusivity may preserve the startup's customer diversity. By contrast, considering only startups willing to accept every purchasing condition imposed by the group prioritizes procurement convenience without establishing whether their shares offer an attractive investment.
Revisions need accountable owners and supporting evidence. If repeated reviews show that integration takes longer than expected, the response should be to revise timing and budgets while preserving security requirements. Documented learning can justify changing a thesis. Rewriting it merely to accommodate an executive's preferred opportunity makes it difficult to determine whether selection remains coherent or whether the exceptions have displaced the strategy.
Treat internal sponsorship as operating capacity
An internal sponsor turns interest into access to scarce resources: users, specialists, permitted data, a testing environment, and decision-making time. A name on an application is insufficient. Establish which problem that person owns, what budget they control, and who can authorize execution. An enthusiastic director may have influence but still lack the authority to provide an integration team or approve necessary data processing.
A verifiable commitment identifies responsibilities and deadlines. The user department explains the existing process and supplies a performance baseline. Technical staff estimate integration work. Security and privacy teams assess the proposed design. Procurement clarifies the contracting route. The sponsor resolves competing priorities and accepts the expected internal costs. Together, these commitments establish whether the corporation can test the solution before startup delays are attributed solely to the founders.
Access to experts works best through sessions with defined questions and deliverables. An engineer can assess fault tolerance; operations staff can explain the consequences of an incorrect recommendation; procurement can assess recurring purchasing requirements. Each opinion should remain connected to the specialist's competence. Deep operational knowledge is valuable evidence, but does not by itself qualify someone to determine the value of an equity stake.
Plan for the sponsor's replacement. A role change or shift in priorities can end support without changing the startup's quality. A second accountable person, an identified budget, and recorded decisions reduce this vulnerability. If the entire investment case disappears when one executive leaves, that dependency should influence risk assessment, the commercial plan, and the acceptable investment price.
Separate equity, debt, and commercial purchasing
Equity investment purchases rights in a company and exposes the investor to possible loss of capital. Debt creates payment obligations under agreed terms, subject to default risk and the effectiveness of contractual protections. A commercial contract pays for a delivery, license, or service. One relationship may combine these arrangements, but each needs its own purpose, budget, approval, and records so its obligations remain understandable.
This separation prevents a common mistake: treating pilot payments as invested capital or presenting a purchase as an equity return. When a corporation purchases a service, it receives the contracted performance. The resulting revenue belongs to the startup and funds costs, taxes, investment, and other needs. Shareholders do not automatically receive their ownership percentage of that payment. Distributions and exits depend on economic conditions and applicable rights.
Debt and convertible instruments require their own analysis. A loan does not become equity because its lender has strategic interests. Conversion can depend on events, formulas, and decisions that determine the resulting quotas or shares. Security, maturity, priority, and conversion terms change the risk. Documentation should explain what happens if an expected financing round never occurs or the startup runs short of cash beforehand.
The instrument must suit the entity's actual legal position in Brazil. A business registered as MEI cannot admit equity partners while remaining MEI; an appropriate structure must be assessed before an equity investment. A donation to a nonprofit creates neither an equity stake nor a promised financial return. Loans, receivables transactions, equity, convertibles, and donations create different rights and risks. Calling an arrangement innovative does not erase those differences.
Apply exclusion criteria before comparing eligible opportunities
Selection works better when clear impediments are checked before eligible opportunities are compared. Missing essential product rights, refusal to explain how funds will be used, or dependence on unavailable authorization may prevent progress. Such problems should not disappear inside an average score. An excellent sales team cannot compensate for an inability to use the technology legally, even if other aspects of the proposal are compelling.
For eligible projects, a matrix can organize strategic fit, demand evidence, technical capability, delivery economics, team quality, and investment terms. Its weights express choices within the thesis rather than universal truths. More useful than a standalone score is a reasoned assessment linked to evidence and unresolved questions. Similar overall assessments may conceal very different risks: one startup knows its costs, while another depends on an untested integration.
Keep business quality separate from transaction attractiveness. A convincing product can come with ownership terms that make investing inappropriate. An apparently inexpensive stake can require further financing beyond the startup's ability to execute or the investor's willingness to provide. Comparing companies without comparing prices, rights, and future cash requirements leaves the decision incomplete. A sound business and an acceptable transaction must each be established.
The committee should record both the reason to proceed and the strongest argument against doing so. This reduces the influence of persuasive presentations and supports later review. When evidence changes, reviewers can identify the affected assumption. The matrix makes judgments open to challenge and traceable; it should not manufacture objectivity through decimal places, unsupported rankings, or automated classifications that exceed the quality of the underlying information.
Focus diligence on the assumptions that drive value
Effective diligence concentrates effort on claims supporting the thesis. If the solution supposedly reduces losses without replacing equipment, review results, operating conditions, and integration dependencies. If its advantage is replication across customers, examine the custom work each deployment requires. A substantial document collection can support this process, but cannot replace questions connecting evidence to value creation. The review should test the proposed mechanism rather than merely confirm that files exist.
Distinguish observed facts, management statements, and projections. A signed contract evidences the obligations it contains, subject to interpretation and performance; it does not prove renewal. An expression of interest is not contracted revenue. Existing eligible receivables differ from hoped-for sales. Eligibility, enforceability, collection risk, and timing require assessment rather than assumption. A documented payment claim and a sales forecast should not receive identical evidential weight.
Investors may request reconciliation among contracts, billing, collections, and material costs, using proportionate access and information protection. Customer concentration, cancellations, rework, and support hours also matter. Revenue from the sponsoring group deserves particular attention in CVC. It may reflect genuine demand, but could also rely on exceptional terms, executive support, or corporate resources that would not be available when selling to independent customers.
Corporate, accounting, legal, and security matters require appropriately qualified professionals. Diligence aims to identify exposure, estimate consequences, and assess feasible remedies, rather than promise an absence of problems. Material issues may become funding conditions, price adjustments, or grounds for rejection. An unanswered question should remain an identified uncertainty. A tight timetable does not justify converting missing information into a favorable conclusion.
Design a pilot that can disprove the thesis
A pilot should answer a limited, relevant question. Testing whether a solution reduces a defined process failure differs from proving readiness for deployment across an entire corporate group. Establish a baseline, observed population, duration, measurement method, and stopping criteria. Identify who generates data and who checks results. Without this preparation, improvements can be credited to the product while failures are routinely blamed on the environment.
Metrics should combine technical performance with economic consequences. A more accurate recommendation may create no savings if it arrives too late or requires expensive manual review. Relevant measures may include response time, availability, operating hours, integration costs, and serious error frequency. Safety or compliance requirements may be essential even when average performance looks favorable. A favorable average cannot justify ignoring failures whose consequences exceed the agreed tolerance.
Define routes for approval, extension, and termination. An extension should address a specific evidence gap within a limited budget and period. Repeated testing can transfer research costs to the startup while postponing a difficult decision. Conversely, meeting one metric does not require a scaled purchase: support capacity, recurring pricing, and deployment requirements still need assessment. The pilot's decision rules should match what it can actually establish.
Before execution, record that technical acceptance, commercial purchasing, and investment are separate decisions. A pilot may demonstrate usefulness while revealing an unattractive investment at the requested price. It may fail in the chosen application yet suggest another market, without justifying an improvised change to the thesis. Learning has value, but should be described as learning and evaluated on that basis rather than labeled a financial return.
A numerical example with separate cash flows and rights
Consider a wholly hypothetical case, with figures chosen only to demonstrate arithmetic. A corporation values an industrial analytics startup at R$ 8 million before investment and invests R$ 2 million in newly issued ordinary shares. Ignoring transaction costs in this initial calculation, the post-money valuation is R$ 10 million and the acquired stake is 20%. That negotiated valuation does not represent cash available for redemption or establish that a buyer exists.
Under a separate contract, the corporation buys a pilot for R$ 240,000. Direct delivery costs for the startup are R$ 180,000. The R$ 60,000 difference precedes overhead, taxes, and other effects; it is neither net profit nor a payment to the investor. The corporation also expects R$ 60,000 of internal work. Its commercial and operating expenditure therefore totals R$ 300,000, in addition to the R$ 2 million equity investment.
Suppose a later round contributes R$ 5 million at a R$ 15 million pre-money valuation and R$ 20 million post-money valuation. The new investor receives 25%. If the corporation does not participate and no other ownership changes occur, its stake falls from 20% to 15%: 20% multiplied by the 75% retained by existing shareholders. Options, convertibles, preferences, and additional issuances are excluded; any such arrangements would need to be incorporated.
The records should show three distinct facts: R$ 2 million purchased equity, R$ 240,000 paid for the contracted delivery, and R$ 60,000 funded the corporation's internal work. Combining them all as the purchase price of the stake misstates the equity transaction. Ignoring the latter two amounts understates the partnership budget. Investors need both views: the economics of their ownership and the full resources committed to making the relationship work.
Schedule cash and decisions without automatic commitments
In the same hypothetical example, the pilot lasts three months, with R$ 80,000 paid for each stage. Assume startup direct costs of R$ 60,000 and corporate internal costs of R$ 20,000 each month. If payments occur as planned, the startup's monthly difference is R$ 20,000 before other expenses. Totals are R$ 240,000 received, R$ 180,000 in direct costs, and R$ 60,000 accumulated before those additional expenses.
The R$ 2 million investment closes separately, after the agreed equity conditions are satisfied. Its use should follow the approved plan rather than be described as an advance pilot payment. This separation clarifies delays. If the corporation provides data late and postpones a commercial stage, the delivery impact belongs under the relevant commercial contract. Investment rights should not change silently because a different part of the relationship has encountered difficulty.
There are at least three decisions: authorize a test with defined resources and responsibilities; decide on equity ownership following diligence and negotiation; and assess recurring purchasing after the pilot. Their order can vary with evidence and funding needs, but dependencies must be explicit. Investing before testing accepts greater technical uncertainty. Purchasing a test does not automatically commit either party to an equity transaction or a continuing service agreement.
The schedule must address cash mismatches. If the first commercial payment is one month late, the startup may need to finance R$ 60,000 of direct costs before receiving payment. A positive overall pilot balance does not remove that temporary funding requirement. The committee should know who bears delays, the exposure limit, and when work will stop. Payment timing remains an economic variable even when the total contract price is unchanged.
Model equity proceeds, dilution, and adverse outcomes
Continuing the hypothetical example, suppose a future sale has an enterprise value of R$ 40 million, with R$ 4 million of debt to repay and R$ 1 million of transaction expenses. Assume no surplus cash and proportional distribution among ordinary shares without preferences. Shareholders would receive R$ 35 million. A 15% stake would yield R$ 5.25 million: 2.625 times the R$ 2 million investment, with a gross positive difference of R$ 3.25 million.
This calculation excludes taxes, investor costs, elapsed time, contingent payments, and subsequent ownership changes. It is therefore neither an annualized rate nor a promise. The R$ 300,000 associated with the pilot and internal work remains part of the partnership budget. Assess its economic value through the service and learning obtained. It should not be added to sale proceeds or represented as an equity distribution.
For an adverse scenario, retain the debt and expenses but reduce enterprise value to R$ 8 million. Shareholders would receive R$ 3 million, and 15% would equal R$ 450,000. The loss against the original investment would be R$ 1.55 million before other effects. At an enterprise value of R$ 5 million, the arithmetic residual would be zero. Actual insolvency procedures and payment priorities can make distributions more complicated.
Other scenarios never reach a sale. A startup may operate for years without a buyer, need further rounds, or accept terms that dilute existing shareholders. A successful pilot removes none of these possibilities. Examine dependence on a particular exit and whether potential buyers would face conflicts with the sponsor. An estimated paper value differs from realizable liquidity; approval, repayment, profitability, liquidity, and preservation of capital are not guaranteed.
Assess intellectual property before funding substantial adaptations
Review intellectual property before the corporation finances major adaptations. Establish ownership of code, models, trademarks, relevant databases, and third-party components. Check whether employees and contractors have formalized necessary rights and what obligations external licenses impose. A functioning product may still face use or transfer restrictions that affect investment value. Technical performance alone cannot establish that the startup owns, controls, or may commercially exploit everything its product requires.
Negotiations commonly distinguish pre-existing technology, project-specific development, and general improvements. A startup might retain its core product while licensing the contracted use. A customization funded by the corporation may receive separate treatment. There is no universal arrangement, but wording should not accidentally give the customer every improvement developed during the relationship, including improvements that could serve the entire market. Such terms can change the economics of scaling.
Data and outputs need separate rules. Access to operational information does not authorize reuse for other customers or model training. Contracts should address purpose, access, retention, return or deletion, and derived materials. Where personal data is involved, assess responsibilities and appropriate measures with specialist assistance and attention to guidance from Brazil's ANPD. Permission for a limited pilot should not be assumed to cover every later technical or commercial use.
The central investment question is whether the arrangement preserves a commercially viable company. A broad assignment might solve the sponsor's immediate problem while stripping the startup of its principal asset. An inadequate license could leave the corporation dependent on a supplier without reasonable continuity arrangements. Usage rights, support, and transition provisions should balance these exposures through explicit costs and limits, rather than shifting every uncertainty to one party.
Preserve commercial independence and exit alternatives
Commercial independence lets the startup sell to other customers and test demand beyond its strategic investor. This can diversify revenue, produce external references, and reduce dependence on one chain of decisions. It may also preserve potential buyers in an exit. Specific commercial commitments remain possible, but their scope and consequences require assessment. The ability to win independent business is evidence about the product's broader usefulness and commercial economics.
Broad exclusivity may appear advantageous to the corporation while blocking the startup's market. A ban on selling throughout an industry without a corresponding purchase commitment exchanges market access for an expectation. Negotiable alternatives can limit application, territory, duration, consideration, and termination conditions. Even a narrower restriction has a cost: estimate forgone revenue and how difficult it would be to regain access to that market after the restriction ends.
Acquisition preference rights and similar negotiation rights also deserve care. Depending on their design, another buyer may abandon diligence if the strategic investor can take over the transaction at the end. Compare the corporation's protection with any reduction in competition for future financing rounds or a company sale. The broadest contractual right does not necessarily produce the best economic outcome for the corporation's existing stake.
Independence also affects pricing and information access. A corporate investor should not automatically receive competitors' proposals, confidential customer data, or sensitive commercial terms without a legitimate purpose and appropriate controls. Separating teams and restricting information flows may make otherwise impractical relationships possible. Specific competition concerns need their own legal analysis. Shareholder access rights and commercial information requests should be evaluated according to their actual purpose and legal basis.
Establish governance for disagreements and conflicts
In CVC, one corporation can be shareholder, customer, and potential acquirer. These roles create concrete tensions. As a customer, it may seek lower prices and exclusive customization. As a shareholder, it may benefit from sustainable margins and expansion to other buyers. As an acquirer, it may prefer a lower company price. Governance should recognize these conflicts before an urgent negotiation makes them harder to manage.
A functional division of responsibilities helps. Investment staff assess equity price, rights, and risk. The user department owns operational results. Procurement negotiates purchasing within commercial parameters. Legal, security, and privacy specialists review their respective subjects. The committee receives a synthesis and decides with disagreements recorded. Expert advice supports the decision without displacing the responsibility of whoever authorizes the expenditure or approves the relevant commitment.
Managing a conflict may require restricting document access, excluding a representative from a particular decision, or obtaining an independent assessment. The procedure must fit the contracts and ownership structure. A governance seat does not authorize using startup information for the corporate group's commercial advantage. Conversely, confidentiality arrangements should not prevent other investors from receiving information to which they are entitled. Controls should address the specific conflict rather than merely acknowledge it.
Disagreement can be productive when framed as a testable proposition. If operations expects easy integration and technology staff foresee extensive work, commission a diagnosis with limited scope and timing before making a broad commitment. If investment staff reject the price but the sponsor wants the product, purchasing may proceed on its own merits. Commercial urgency does not resolve a disagreement about equity value or justify bypassing the investment analysis.
Monitor performance, dependence, and cash consumption separately
Post-investment monitoring should revisit the approved assumptions. Is the startup selling to independent customers? Are deployment costs falling? Does recurring revenue cover service effort? Can available cash fund the next milestones? Reports should answer these questions rather than merely list meetings, activities, and announcements. Frequency and detail should reflect risk and maturity. Monitoring is useful when it supports decisions about the assumptions that originally justified committing capital.
Separate business, partnership, and ownership indicators. Business measures cover revenue, concentration, costs, and cash. Partnership measures cover operational results, actual use, and internal effort. Ownership measures cover the current stake, rights, new issuances, and liquidity alternatives. This prevents success in one dimension from hiding deterioration elsewhere. A well-received deployment can coexist with unsustainable cash consumption, and a useful commercial relationship may still accompany a declining investment position.
Set action thresholds before a crisis. Growing dependence on the corporation may require revising the sales plan. Repeated delivery delays may call for narrower scope. An earlier-than-expected financing round requires a fresh assessment of budgets and terms, without assuming existing investors will participate. Further funding should be justified by its merits and additional risk, rather than by a desire to avoid recognizing problems with the previous investment.
Monitor the sponsor as well. Slow approvals, changing priorities, and insufficient staffing can destroy partnership value. Recording these factors avoids assigning every failure to the startup and enables internal correction. If the thesis no longer fits the corporation, manage the relationship with clear contractual boundaries. Existing obligations and viable continuity options still matter even when strategic enthusiasm declines or the organization decides against providing further support.
Correct recurring mistakes in ways that change decisions
One recurring error is choosing a startup because of a powerful sponsor and constructing the thesis afterward. Apply the same evidence, pricing, and independence requirements used for other opportunities. Another is treating a pilot as a free favor. Define delivery, compensation, and both parties' costs, including specialist hours and integration. Apparent free access can conceal subsidies that make the commercial arrangement impossible to repeat elsewhere.
Contracted revenue is also mistaken for proof of a broader market. An agreement with the investor can support initial operations without showing that independent customers will accept the same product and price. Seek external evidence and identify exceptional terms in the relationship. The findings might justify a lower valuation, investment conditional on further milestones, or retaining only the commercial contract. Each is a legitimate outcome of the analysis.
Excessive protections can leave the startup unable to raise funds or sell. Exclusivity, broad approval requirements, and technology rights may each seem prudent but form an unfinanceable package when combined. Assess their cumulative effect and negotiate what is necessary for legitimate purposes. Contractual protection should be considered alongside the value of the asset being protected. Rights that undermine the startup's business can weaken the investment they were intended to safeguard.
A failed pilot does not require searching for a secondary metric to declare success. Preserve the result, explain limitations, and decide whether a genuinely different hypothesis warrants a separate test. If data arrived late, correct the design and estimate the new cost. If the product misses an essential requirement, end that application. This discipline turns mistakes into usable evidence rather than obscuring them through a favorable retrospective narrative.
Document the reasoning and choose a clear course of action
The final assessment should let another person reconstruct the reasoning: selected problem, corporate contribution, business evidence, price, rights, use of funds, risks, and stopping conditions. Identify outstanding checks and their owners. Precision should not be promised where uncertainty remains. Instead, explain which uncertainties are being accepted and why potential returns justify bearing them. The document should support an informed decision rather than merely preserve the presentation that secured attention.
A project-based approach can organize capital needs, deliverables, documents, and monitoring criteria. In this context, KEZS connects entrepreneurial projects and potential funders through technology and intermediation. Its potential usefulness is in helping proposals become easier to understand and compare. Investors conduct their own diligence and make their own decisions. KEZS does not assign a credit score; organized documentation is neither investment approval nor a guarantee of repayment or performance.
The transaction structure requires separate review. Public securities distribution and regulated financial activities need appropriate structures and providers; technology or a Brazilian CNAE activity classification is not authorization. CVM materials on offerings and funds, Banco Central materials on correspondents, and relevant ANPD guidance are reference entry points, not evidence that KEZS is authorized. Keep private documents in access-controlled environments rather than publishing them on public blockchains.
Before deciding, explain why equity ownership is appropriate, why the price is acceptable, what evidence is missing, who supports the pilot, and how the startup retains its market and technology. Blockchain integrity does not establish truth, legal title, reserve solvency, or payment guarantees. Choose explicitly among investing, purchasing, further investigation, and rejection, with defined budgets and responsibilities. Clear documentation supports judgment without eliminating uncertainty, conflicts, costs, or the possibility of loss.
Frequently asked questions.
Does a startup need an internal sponsor to be a good CVC investment?
It depends on the strategic mechanism in the thesis. If value creation requires access to corporate operations, the absence of someone with resources and authority weakens the proposal. A thesis focused on learning about an adjacent market may involve a different relationship. Informal enthusiasm should not be presented as available operating capacity. The assessment should identify which benefits depend on sponsorship, who can deliver them, and what happens if support ends. A replacement plan can reduce dependence on one person, but cannot substitute for resources that were never committed.
Is it better to invest before or after the pilot?
The answer depends on what the test can establish, the startup's funding needs, and the negotiated terms. Waiting may reduce technical uncertainty, but does not ensure that a stake will remain available at the same price. Investing earlier can fund development and bring earlier access while exposing the investor to greater uncertainty. Compare the cost of waiting with the possible loss from committing too soon. In either sequence, keep the equity closing separate from the commercial purchase and state their dependencies. Neither sequence guarantees approval or a favorable outcome.
How should investors assess a startup that depends almost entirely on the corporate investor?
Distinguish temporary concentration from structural dependence. An initial customer can help validate a product, but exclusive adaptations, subsidized pricing, and exceptional access to corporate teams may obstruct expansion. Examine how the product would work for other customers, what deployment would cost, and whether contracts permit those sales. Assess whether support and pricing are commercially repeatable. If diversification is implausible, the relationship may resemble that of a specialist supplier, requiring a different justification for equity ownership. Revenue from the sponsor is evidence of that relationship, not automatic proof of an independent market.
Can exclusivity be part of a sound negotiation?
Yes, provided its purpose and cost are understood. A limited scope, defined duration, consideration, and termination conditions make the exchange easier to assess. Restricting a specific application differs from preventing sales throughout an industry. Estimate sacrificed business, consequences for later funding, and effects on exit alternatives. Exclusivity without a purchase commitment can leave the startup bearing the cost of a commercial option the corporation may never exercise. A narrower clause may reduce that exposure, but still requires analysis of its economic consequences and interaction with other contractual rights.
How should strategic benefits be treated when financial returns are uncertain?
Give strategic benefits their own budget, accountable owner, and measurement method. Estimate cost reductions against a verifiable baseline, including implementation, maintenance, and adverse effects. Savings belong to the operation achieving them and should not be presented as distributions from the startup. A committee can accept a combination of strategic and financial objectives, but should disclose the criteria and uncertainties. It should also establish that the equity expenditure is justified as investment rather than merely financing a purchase that needs its own commercial contract and budget. Learning and financial proceeds remain distinct outcomes.
How can a committee know when diligence is sufficient to decide?
There is no universal document count. Diligence approaches sufficiency when material assumptions have been examined, important gaps are identified, and remaining risks can be accepted, limited, or reflected in terms. Unresolved ownership of essential technology may block funding. An uncertain sales estimate may be compatible with the startup's stage if its cash and plan can withstand variations. The decision maker should explain why each open issue does not prevent disbursement, who owns any remedy, and whether a condition must be satisfied first. Sufficient diligence supports judgment; it cannot establish that every problem has been found.
What if the pilot works but the investment terms are unattractive?
The corporation can purchase the solution and decline the equity stake. A successful test addresses an operational question; price, dilution, governance, and liquidity require a separate assessment. The parties may negotiate different terms or await further evidence, without assuming an agreement will follow. Preserving this independence avoids using the investment budget to justify purchasing. It also allows a useful commercial relationship to continue when ownership interests do not align. The pilot should retain its actual result, while the investment decision records why those results do not outweigh the proposed transaction's costs and risks.
References and context
Institutional reference points for checking applicable rules and guidance. Calculations and scenarios are original examples, not quotes, historical results or individualized recommendations.
- Banco Central — correspondentes no País ↗
- CVM — Resolução 88, texto e alterações ↗
- CVM — Resolução 175, fundos de investimento ↗
- Portal do Empreendedor — perguntas sobre MEI ↗
- ANPD — orientações e perguntas frequentes ↗
AI-assisted educational content. Decisions require verification of the information, instruments and providers in each actual case.
